As the global economy mends, the 2021 growth of Point-Of-Care Or Rapid Diagnostics will have significant change from previous year. According to our (researcher) latest study, the global Point-Of-Care Or Rapid Diagnostics market size is USD million in 2022 from USD 25110 million in 2021, with a change of % between 2021 and 2022. The global Point-Of-Care Or Rapid Diagnostics market size will reach USD 48170 million in 2028, growing at a CAGR of 9.8% over the analysis period.
The United States Point-Of-Care Or Rapid Diagnostics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Point-Of-Care Or Rapid Diagnostics market, reaching US$ million by the year 2028. As for the Europe Point-Of-Care Or Rapid Diagnostics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Point-Of-Care Or Rapid Diagnostics players cover Roche, Abbott, Danaher, and Siemens Healthcare, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Point-Of-Care Or Rapid Diagnostics market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Intensive Care
Covid-19 Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinic
Independent Laboratories
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Roche
Abbott
Danaher
Siemens Healthcare
Bio-Rad Laboratories
BioMerieux
Nova Biomedical
Thermo Fisher Scientific
Quidel
A. Menarini Diagnostics
Becton Dickinson
Biosurfit
Astrego Diagnostics
Werfen
Abionic
Palex Medical/Bülhmann
Horiba Medical
RAL
Vircell
Monlab
Binding Site